FFCP PHASE1:Mm9::chr7:19017382..19017414,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=114871|HGNC=|MCL_coexpression_id=31|UniProt=Q4KL66|association_with_transcript=0bp_to_ENSMUST00000019291,NM_054063,uc009fjk.2_5end|description=CAGE_peak_1_at_Psg28_5end|id=chr7:19017382..19017414,-|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0001962!1.24e-43!2;UBERON:0001961!1.24e-43!2;UBERON:0001744!1.24e-43!2;UBERON:0005631!4.03e-30!3;UBERON:0000478!4.03e-30!3;UBERON:0000158!4.03e-30!3;UBERON:0002465!1.54e-29!3;UBERON:0000305!5.07e-23!1;UBERON:0003199!8.39e-23!1;UBERON:0004923!2.55e-15!24;UBERON:0001987!2.42e-12!2;UBERON:0003124!2.42e-12!2;UBERON:0004340!2.42e-12!2;UBERON:0004871!1.34e-08!3;UBERON:0007023!1.20e-07!51;UBERON:0005795!8.08e-07!4;UBERON:0000995!8.08e-07!4;UBERON:0000344!8.85e-07!15|ontology_enrichment_uberon_v019_2=UBERON:0005631,3.28e-58,3;UBERON:0000478,3.28e-58,3;UBERON:0000158,3.28e-58,3;UBERON:0000305,7.47e-44,1;UBERON:0001987,5.75e-23,2;UBERON:0003124,5.75e-23,2;UBERON:0004340,5.75e-23,2;UBERON:0004871,1.12e-15,3;UBERON:0005795,3.12e-12,4;UBERON:0000995,3.12e-12,4;UBERON:0003975,4.56e-10,5;UBERON:0004923,1.75e-08,24;UBERON:0003134,8.61e-07,8|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.159992422793407,0.45881856213434,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.6293836125781,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,111.847333416097,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p1@Psg28}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=114871 | |||
|HGNC= | |||
|MCL_coexpression_id=31 | |||
|TSSclassifier=NA | |||
|UniProt=Q4KL66 | |||
|association_with_transcript=0bp_to_ENSMUST00000019291,NM_054063,uc009fjk.2_5end | |||
|cluster_id=chr7:19017382..19017414,- | |||
|description=CAGE_peak_1_at_Psg28_5end | |||
|id=chr7:19017382..19017414,- | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0001962!1.24e-43!2;UBERON:0001961!1.24e-43!2;UBERON:0001744!1.24e-43!2;UBERON:0005631!4.03e-30!3;UBERON:0000478!4.03e-30!3;UBERON:0000158!4.03e-30!3;UBERON:0002465!1.54e-29!3;UBERON:0000305!5.07e-23!1;UBERON:0003199!8.39e-23!1;UBERON:0004923!2.55e-15!24;UBERON:0001987!2.42e-12!2;UBERON:0003124!2.42e-12!2;UBERON:0004340!2.42e-12!2;UBERON:0004871!1.34e-08!3;UBERON:0007023!1.20e-07!51;UBERON:0005795!8.08e-07!4;UBERON:0000995!8.08e-07!4;UBERON:0000344!8.85e-07!15 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0005631,3.28e-58,3;UBERON:0000478,3.28e-58,3;UBERON:0000158,3.28e-58,3;UBERON:0000305,7.47e-44,1;UBERON:0001987,5.75e-23,2;UBERON:0003124,5.75e-23,2;UBERON:0004340,5.75e-23,2;UBERON:0004871,1.12e-15,3;UBERON:0005795,3.12e-12,4;UBERON:0000995,3.12e-12,4;UBERON:0003975,4.56e-10,5;UBERON:0004923,1.75e-08,24;UBERON:0003134,8.61e-07,8 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.159992422793407,0.45881856213434,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.6293836125781,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,111.847333416097,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p1@Psg28 | |||
}} |
Latest revision as of 07:43, 26 September 2015
Short description: | p1@Psg28 |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_1_at_Psg28_5end |
Coexpression cluster: | MCL_coexpression_mm9:31 |
Association with transcript: | 0bp_to_ENSMUST00000019291, NM_054063, uc009fjk.2_5end |
EntrezGene: | Psg28 |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
extraembryonic membrane | 3.28e-58 | 3 |
extraembryonic structure | 3.28e-58 | 3 |
membranous layer | 3.28e-58 | 3 |
amnion | 7.47e-44 | 1 |
placenta | 5.75e-23 | 2 |
chorion | 5.75e-23 | 2 |
allantois | 5.75e-23 | 2 |
somatic layer of lateral plate mesoderm | 1.12e-15 | 3 |
embryonic uterus | 3.12e-12 | 4 |
uterus | 3.12e-12 | 4 |
internal female genitalia | 4.56e-10 | 5 |
organ component layer | 1.75e-08 | 24 |
female reproductive organ | 8.61e-07 | 8 |